A month by month record of what Mammologix has delivered, what is underway, and what is planned. Written for the clients and readers who want to follow the work rather than hear about it once a year.
Last Reviewed: August 25, 2026
MammoComply Alert: FDA Certificate Delivery Is Changing, Effective Today
Notice
FDA Certificate Delivery Is Changing, Effective Today
Starting today, September 14, 2026, the FDA is transitioning MQSA certificate and letter delivery away from postal mail and onto a new online system, the MQSA Facility Portal. Full implementation completes October 22, 2026.
As your Fulfillment Partner, our support team works diligently to track FDA and MQSA program changes like this as part of our MammoComply service, so you don't have to catch it on your own or find out about it at inspection.
We've prepared a complete advisory covering exactly what's changing, who is affected, and the specific steps your facility should take before the transition completes, including verifying your FDA contacts and updating your download and display procedure.
Be sure to share this with the Accreditation Contact, the Most Responsible Individual, and the Inspection Contact. You may also want to share it with your Practice Administrator, Quality Assurance Manager, Lead Interpreting Physician, or anyone else involved in the compliance process at your location.
This is the kind of regulatory tracking and translation we handle for our client facilities every day. If you have questions about how this applies to your facility, or want help walking through the checklist, reach out to us anytime.
Mammologix August 2026 Update | New Resources, Tools & Labor Day Hours
Warm greetings from Mammologix as August draws to a close and we prepare to welcome September.
We hope you and your team have enjoyed a wonderful summer, and we appreciate the opportunity to continue supporting your breast imaging program.
Notice
Labor Day Office Hours
In observance of Labor Day, Mammologix will be closed Monday, September 7, and our regular office hours will resume on Tuesday, September 8.
Should you have an immediate need while our office is closed, please call 1-800-739-6919 and ask for the Administrator on Call. We will be happy to assist you.
From all of us at Mammologix, we wish you, your team, and your families a safe and enjoyable Labor Day weekend.
Completed
Introducing Monthly Progress Notes
We are pleased to introduce a new home for our Monthly Progress Notes.
Each month, we provide our clients with an update on what Mammologix is delivering, what is currently underway, what we are planning for the months ahead, and other work and developments we believe you may want to follow.
Beginning with this new format, these updates will also be available on our website so you can easily return to them whenever needed.
Visit Mammologix.com and look for Monthly Progress Notes under Resources in the website footer.
We hope this becomes a useful way to stay connected with the work taking place behind the scenes on your behalf.
Underway
Mammologix's KnowledgeHub Is Moving
Another exciting change is coming during September.
The content you have come to know through the KnowledgeHub is moving directly into Mammologix.com/Resources, where it will become part of our growing Knowledge Hub.
All of your favorite articles, and many new resources, will be brought together in one place alongside our expanding knowledge areas:
Our goal is to make it easier for breast imaging professionals to find practical information, tools, research, operational guidance, and compliance resources without having to search across multiple locations.
Visit Mammologix.com/Resources and explore the Knowledge Hub. Be on the lookout throughout September as even more content makes its way to its new home.
Completed
Featured in MammoToolbox: Downstream Revenue Estimator
Have you ever wondered how much economic impact your breast imaging program creates beyond the mammogram itself?
Breast imaging is often viewed primarily in terms of the examinations performed within the department. But screening can begin a much broader pathway involving diagnostic imaging, biopsy, cancer detection, treatment, and other downstream services throughout the healthcare organization.
The Mammologix Downstream Revenue Estimator was created to help breast imaging leaders explore that bigger picture.
The estimator models a mammography program across three distinct components (the screening base, diagnostic referral base, and downstream cascade) and allows you to replace the model's defaults with information specific to your own practice.
Using published benchmarks, reimbursement information, peer-reviewed literature, and documented assumptions, the calculator provides an interactive way to explore the potential economic contribution generated by your breast imaging program.
Just as importantly, the methodology is transparent. The formulas, assumptions, defaults, methodology notes, and validation work behind the estimator are available for review.
For breast imaging leaders preparing for conversations with administration, finance, or organizational leadership, it can provide an entirely different perspective on the value their program contributes across the larger healthcare enterprise.
Explore the Downstream Revenue Estimator in MammoToolbox.
Planned
Coming This Fall: Complimentary PEMAT Review for Client Patient Letters
Clear communication is an essential part of the patient experience, particularly when patients are receiving information about their mammography results and what they may need to do next.
This fall, Mammologix will begin providing each of our clients with a complimentary review of their patient letters using the AHRQ Patient Education Materials Assessment Tool, or PEMAT, at no additional charge.
Developed by the Agency for Healthcare Research and Quality (AHRQ), the PEMAT provides a structured method for assessing two important characteristics of patient education materials:
Understandability: how effectively patients of different backgrounds and health literacy levels can process and explain the material's key messages.
Actionability: how effectively patients can identify what they should do based on the information provided.
Our courtesy report will give your facility an additional perspective on how its patient letters perform using this established assessment framework. Where opportunities are identified, our team will also be available to discuss the findings and assist with potential improvements you may wish to consider.
The goal is simple: to help ensure that the information reaching your patients is not only delivered reliably, but is as understandable and actionable as possible.
You can also explore the Mammologix PEMAT Scoring Instrument and additional information about the methodology in the MammoToolbox.
Thank You for Allowing Us to Serve You
As always, thank you for the opportunity to support you, your team, and the patients you serve.
For more than 30 years, our work at Mammologix has grown from listening to breast imaging professionals, understanding the challenges they face, and finding practical ways to make their work more visible, dependable, and manageable.
We are grateful to have you as part of the Mammologix community.
If there is ever anything we can do to assist your facility, answer a question, or help you explore an opportunity for improvement, please reach out. We are always glad to help.